Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.2.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
JN.2.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
JN.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDD.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XDD.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDD.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XDD.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XDD.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XDD.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XDD.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDD.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KR.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KR.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KR.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KR.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KR.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KR.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.32EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.32EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.32ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.32ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.32ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.32ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HK.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.13ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HK.13ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HK.13EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HK.13EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HK.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HK.13ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used